Document Classification

Section Type: RESULTS

Text: Fasting and postprandial oxidized fatty acids were reduced in fenofibrate-treated subjects compared with placebo-administered subjects (-15. 3 %, P = 0. 0013, and 31. 0 %, P < 0. 0001, respectively), and fenofibrate therapy lowered fasting and postprandial soluble vascular cell adhesion molecule-1 (VCAM-1) (-10. 9 %, P = 0. 0005, and -12. 0 %, P = 0. 0001, respectively) as well as fasting and postprandial soluble intercellular adhesion molecule-1 (ICAM-1) (-14. 8 %, P < 0. 0001, and -15. 3 %, P < 0. 0001, respectively).